Nifty Pharma has fallen by 12.8 per cent so far this year, with Natco Pharma and Granules India leading the plunge ...

President Donald Trump says he plans to impose tariffs on pharmaceuticals "very shortly," in what could be the next phase of ...

The president is expected to impose tariffs on pharmaceuticals, though full details of the plan have not yet been announced.

On The Readout LOUD podcast, STAT reporters talked with BIO's CEO John Crowley about RFK Jr. and tariffs, and discussed calls ...

Products made here might still depend on materials from overseas. And they might be made on machines needing foreign replacement parts.

Current observations and foresight into the world of biosimilars, GLP-1s, PBM and payer trends, according to Jeff Casberg, MS ...

The National Cancer Institute’s Investigational New Drug program facilitates collaboration, not collusion, with industry for ...

Recent tariffs aimed at encouraging U.S. domestic manufacturing and production have raised concerns about their effectiveness ...

Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it ...

The threat of tariffs has put the pharma industry through the wringer this week. On Wednesday, a week after instituting widespread tariffs and a day after promising that “major” tariffs were headed ...

The number of employees laid off dropped year over year during the first quarter. BioSpace recaps the five largest layoffs, ...

Biotech startups, investors sharpen focus on the commercial potential of drugs to attract acquirers, partners.